Carl Zeiss Meditec, Inc.
Clinical trials sponsored by Carl Zeiss Meditec, Inc., explained in plain language.
-
Laser breakthrough: new procedure aims to zap away nearsightedness
Disease control CompletedThis completed Phase 1 trial tested the VisuMax femtosecond laser to correct nearsightedness (myopia) in 357 adults aged 22 and older. The procedure removes a small lens-shaped piece of the cornea to reshape the eye and improve vision. Researchers measured how well the treatment …
Phase: PHASE1 • Sponsor: Carl Zeiss Meditec, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New lens aims to sharpen vision after cataract surgery
Disease control CompletedThis study tested a new type of artificial lens, called the AT ELANA 841P, for people having cataract surgery. 284 adults with cataracts in both eyes received either the new lens or a standard lens. Researchers measured how well patients could see at different distances and check…
Phase: NA • Sponsor: Carl Zeiss Meditec, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC